Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab. by Powell, JR, Dojcinov, S, King, L, Wosniak, S, Gerry, S, Casbard, A, Bailey, H, Gallop-Evans, E, Maughan, T

Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma. by Eyre, T, Osborne, W, Gallop-Evans, E, Ardeshna, K, Kassam, S, Sadullah, S, Sidra, G, Culligan, D, Arumainathan, A, Shankara, P, Bowles, K, Eyre, D, Peng, Y, Pettengell, R, Bloor, A, Vandenberghe, E, Collins, G